Group 1 - The controlling shareholder of the company, Qin Benjun, plans to transfer 60 million shares (8.09% of total share capital) to Guangzhou Defu Nutrition and will relinquish voting rights for 189,141,310 shares (25.50% of total share capital), retaining 3.00% voting rights [1] - Guangzhou Defu Nutrition will become the controlling shareholder of the company, with Hou Ming and Li Zhenfu as the joint actual controllers [1] - The company intends to acquire 80% of Beijing Jinkangpu Food Technology Co., Ltd. through a share issuance and raise additional funds for purchasing 15.50% equity from natural shareholders Li Yang and Song Jun, as well as covering intermediary fees, transaction taxes, and supplementing working capital [1] Group 2 - The target company specializes in the formulation, production, testing, sales, technological innovation, and services of food nutrition fortifiers, widely used in dairy products, functional beverages, complementary foods, medical foods, and health foods [2] - The target company is a leading enterprise in the food nutrition fortifier sector, supplying nutrition fortifiers to numerous infant formula manufacturers both domestically and internationally [2] - The acquisition will allow the listed company to expand its industrial chain into the nutrition fortifier compounding field, creating a closed-loop from upstream raw materials to downstream formulation solutions, enhancing business synergy and stability [2]

Group 1 - The core point of the article is that Rhine Biology (002166.SZ) is undergoing significant changes in its ownership structure and is planning to acquire a majority stake in Beijing Jinkangpu Food Technology Co., Ltd. [1] - The controlling shareholder, Qin Benjun, intends to transfer 60 million shares (8.09% of total share capital) to Guangzhou Defu Nutrition and will relinquish voting rights for 189,141,310 shares (25.50% of total share capital), retaining only 3.00% voting rights [1] - Following this transfer, Guangzhou Defu Nutrition will become the controlling shareholder, with Hou Ming and Li Zhenfu as the joint actual controllers of the company [1] Group 2 - The target company specializes in the formulation, production, testing, sales, technological innovation, and services of food nutrition fortifiers, which are widely used in dairy products, functional beverages, complementary foods, medical foods, and health foods [2] - The target company is a leading enterprise in the food nutrition fortifier sector, supplying nutrition fortifiers to numerous infant formula manufacturers both domestically and internationally [2] - This acquisition will allow the listed company to expand its industrial chain into the nutrition fortifier compounding field, creating a closed-loop from upstream raw materials to downstream formulation solutions, enhancing business synergy and stability [2]

每经头条（nbdtoutiao）——"一针两千，童颜针年销3亿元"背后：多家关联方注册地"查无此人"，股民 追问"钱呢"！钱氏姐弟几乎"掏空"江苏吴中，公司即将退市 （记者 王晓波） 截至发稿，*ST绿康市值为54亿元。 每经AI快讯，*ST绿康（SZ 002868，收盘价：34.7元）12月15日晚间发布公告称，公司第五届第二十九 次董事会临时会议于2025年12月15日在公司综合办公楼二楼第一会议室以现场结合通讯会议方式召开。 会议审议了《关于2023年员工持股计划预留第二部分受让股份第二个锁定期届满的议案》等文件。 2025年1至6月份，*ST绿康的营业收入构成为：兽药占比61.79%，光伏胶膜占比26.1%，生物农药占比 5.99%，其他占比2.83%，食品添加剂占比2.19%。 ...

据港交所12月10日披露，石药创新制药股份有限公司(简称：石药创新，300765.SZ)向港交所主板递交 上市申请，中信证券为其独家保荐人。据招股书，该公司专注于生物制药、功能性原料及保健食品的研 发、生产与商业化。根据弗若斯特沙利文的资料，自2020年至2024年，按收入和出货量计，该公司始终 保持着全球最大化学合成咖啡因生产商地位。 | [編纂]項下的[編纂]數目 | : [编纂]股H股(視乎[編纂]) | | --- | --- | | [編纂]數目 | :「編纂]股H股(可予[編纂]) | | [編纂]數目 | : [編纂]股H股(可予[編纂]及[編纂]) | | 最高[編纂] | : 每股H股[編纂]港元,另加[編纂] | | | (「編纂]港元,多繳款項可予退還) | | 面值 | 每股H股人民幣1.00元 | | [編纂] | : [編纂] | 自2006年成立以来，该公司始终专注于高质量咖啡因的研发与生产。该公司主要生产用作功能性饮料中 的食品添加剂的咖啡因。根据弗若斯特沙利文的资料，自2020年至2024年，按收入和出货量计，该公司 始终保持着全球最大化学合成咖啡因生产商地位。截至最后实际可 ...

Core Viewpoint - Rhine Biotech (002166) announced a suspension of its stock trading starting December 10 due to plans for a change in control, issuance of shares, and cash payment for asset acquisition, with the suspension expected to last no more than 10 trading days [1] Group 1: Control Change - The controlling shareholder and actual controller, Qin Benjun, is planning to transfer part of his shares and relinquish voting rights [1] - A "Control Change Intent Agreement" has been signed with the counterparty, Guangzhou Defu Nutrition Investment Partnership (Limited Partnership) [1] Group 2: Acquisition Details - Rhine Biotech intends to acquire at least 80% of Beijing Jinkangpu Food Technology Co., Ltd. through a combination of share issuance and cash payment [1] - Following the transaction, Beijing Jinkangpu will become a subsidiary of Rhine Biotech and will be included in the consolidated financial statements [1] - The transaction is not classified as a major asset restructuring or restructuring listing, but it is expected to constitute a related party transaction [1] Group 3: Company Background - Beijing Jinkangpu, established in 2004, specializes in the compounding, testing, sales, and technical development of food nutrition fortifiers [1] - Rhine Biotech's core products include natural sweeteners [1]

证券日报网讯 12月8日，华宝股份在互动平台回答投资者提问时表示，公司始终高度重视全体股东，特 别是中小股东的权益。公司通过坚持稳健的现金分红政策、严格按照法律法规要求履行信息披露义务、 积极通过业绩说明会及互动平台等多种渠道与投资者保持沟通等方式，致力于与股东共享发展成果。目 前，公司暂无其他专门面向中小股东的特定活动计划。未来，公司将继续提升治理水平和投资者关系管 理工作质量，丰富与投资者交流的形式。 （编辑 任世碧） ...

Group 1 - The core point of the article is the announcement by *ST Lvkang regarding its board meeting and the composition of its revenue for the first half of 2025 [1] - The board meeting was held on December 8, 2025, to discuss the proposal for the temporary shareholders' meeting [1] - The revenue composition for *ST Lvkang in the first half of 2025 is as follows: veterinary medicine 61.79%, photovoltaic film 26.1%, biopesticides 5.99%, others 2.83%, and food additives 2.19% [1] Group 2 - As of the report, *ST Lvkang has a market capitalization of 5.7 billion yuan [1]

Group 1: Core Insights - The report highlights a transformation in consumer behavior leading to a new retail system, emphasizing the importance of high-efficiency retail models in the food and beverage sector [13][19][20] - The white liquor industry is experiencing a deep adjustment phase, with growth shifting towards dividend distribution as cash flow remains stable despite declining growth rates [2][40][41] - The dairy sector is moving towards a balance in supply and demand, with structural changes in product categories becoming a focal point for growth opportunities [47][48] Group 2: White Liquor Sector - The white liquor market is facing challenges with overall performance declining, particularly among mid-tier brands, while top brands maintain some resilience [23][30][40] - Key companies like Kweichow Moutai and Wuliangye are adapting to market pressures by adjusting their pricing strategies and focusing on maintaining cash flow and shareholder returns [41][42][43] - The report suggests a focus on brands with strong market positions and core product advantages, indicating that these brands are likely to recover more quickly as market conditions improve [40][41] Group 3: Dairy Sector - The dairy industry is witnessing a gradual stabilization in milk prices as supply-side adjustments occur, with a notable decline in the number of dairy cows [47][48] - There is a growing demand for specific dairy products such as low-temperature fresh milk and specialized infant formula, driven by increasing health awareness among consumers [48][49] - Companies like Yili and Mengniu are expected to perform well due to their strong market positions and ability to adapt to changing consumer preferences [48][49] Group 4: Food Additives and Snacks - The food additives market is benefiting from a global trend towards health-conscious consumption, with companies in this sector experiencing strong export performance [4][13] - The snack food segment is highlighted for its potential growth driven by consumer demand for healthier options and innovative products [5][6] - Brands that can effectively navigate the changing retail landscape and consumer preferences are likely to see significant growth opportunities [5][6][19]

证券日报网讯三元生物11月25日发布公告，在公司回答调研者提问时表示，据公司了解，行业内普遍以 销定产，企业通常仅维持用于平衡生产节奏的必要库存，不存在因反倾销调查而积压大量库存的情形。 从市场价格来看，赤藓糖醇目前处于底部运行。公司在确保成本可控和维持合理价差的前提下，主动通 过适度的价格策略加强客户合作与市场拓展，使产品竞争力和销量均得到一定加强。 （文章来源：证券日报） ...

天眼查App显示，近日，保定锐奥食品添加剂有限公司成立，法定代表人为郑娇，注册资本50万人民 币，经营范围为一般项目：食品添加剂销售;技术服务、技术开发、技术咨询、技术交流、技术转让、 技术推广;互联网销售（除销售需要许可的商品）（除依法须经批准的项目外，凭营业执照依法自主开 展经营活动）许可项目：食品添加剂生产（依法须经批准的项目，经相关部门批准后方可开展经营活 动，具体经营项目以批准文件或许可证件为准）。 ...